T T Lah

Summary

Affiliation: University of Ljubljana
Country: Slovenia

Publications

  1. ncbi Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    T T Lah
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Clin Cancer Res 6:578-84. 2000
  2. ncbi Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases
    A Premzl
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Jamova, Ljubljana, Slovenia
    Biol Chem 382:853-7. 2001
  3. ncbi Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas
    M Trinkaus
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 20:50-9. 2005
  4. pmc Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
    A Schweiger
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Ljubljana, Slovenia
    Br J Cancer 82:782-8. 2000
  5. ncbi Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel
    S Caserman
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 19:120-9. 2004
  6. ncbi Proteases in brain tumour progression
    N Levicar
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Acta Neurochir (Wien) 145:825-38. 2003

Collaborators

Detail Information

Publications6

  1. ncbi Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    T T Lah
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Clin Cancer Res 6:578-84. 2000
    ..We conclude that CatB is useful as a prognostic indicator in lymph node-negative patients. This suggests that selective adjuvant therapy should be applied in this lower risk group of patients when high levels of CatB are determined...
  2. ncbi Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases
    A Premzl
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Jamova, Ljubljana, Slovenia
    Biol Chem 382:853-7. 2001
    ..7+/-1.8%). We conclude that both cysteine and aspartic proteinase activities are needed for invasion by MCF-10A neoT cells in vitro...
  3. ncbi Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas
    M Trinkaus
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 20:50-9. 2005
    ..The diagnostic and prognostic value for relapse of meningioma needs to be confirmed in a larger population of patients...
  4. pmc Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
    A Schweiger
    Jozef Stefan Institute, Department of Biochemistry and Molecular Biology, Ljubljana, Slovenia
    Br J Cancer 82:782-8. 2000
    ..g. cathepsin B and cathepsin L. Variations between tissue and serum levels of Cath H indicate either reduced expression or enhanced secretion of this enzyme in lung tumours...
  5. ncbi Comparison of expression of cathepsins B and L and MMP2 in endothelial cells and in capillary sprouting in collagen gel
    S Caserman
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Int J Biol Markers 19:120-9. 2004
    ....
  6. ncbi Proteases in brain tumour progression
    N Levicar
    Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia
    Acta Neurochir (Wien) 145:825-38. 2003
    ....